| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP &Chief Accounting Officer
1 company
Thomsen Jillian B. is a Chief Financial Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $20.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2020 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 11,976 | $16.93 | $202,753.68 | -7.0% | |
| Aug 17, 2020 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,367 | $19.67 | $26,888.89 | -0.8% | |
| May 18, 2020 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,367 | $22.51 | $30,771.17 | -0.8% | |
| Feb 18, 2020 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,394 | $22.35 | $31,155.90 | -0.8% | |
| Feb 6, 2020 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sale+OE | 37,500 | $22.78 | $854,250.00 | -17.6% | |
| Nov 18, 2019 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 2,713 | $17.97 | $48,752.61 | -1.7% | |
| Aug 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,809 | $18.15 | $32,833.35 | -1.1% | |
| May 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,928 | $31.37 | $60,481.36 | -1.2% | |
| Feb 19, 2019 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,808 | $42.39 | $76,641.12 | -1.1% | |
| Feb 4, 2019 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sale+OE | 16,119 | $42.16 | $679,577.04 | -8.7% |